These final results, together with a past report showing that a little-molecule ACKR3 agonist CCX771 reveals anxiolytic-like behavior in mice,2 support the idea of targeting ACKR3 as a novel way to modulate the opioid procedure, which could open up new therapeutic avenues for opioid-associated disorders. Can help to cut https://stanleyk406gxn2.targetblogs.com/profile